Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line
Molecules · 27.01.2023 · 28 (3) · 1261
DOI: 10.3390/molecules28031261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 27.01.2023. Verfasst von Rosaria Maria Pipitone und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Curcumin, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Siciliana, university of palermo, PO FESR Sicilia 2014/2020.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is an emerging chronic liver disease worldwide. Curcumin and andrographolide are famous for improving hepatic functions, being able to reverse oxidative stress and release pro-inflammatory cytokines, and they are implicated in hepatic stellate cell activation and in liver fibrosis development. Thus, we tested curcumin and andrographolide separately and in combination to determine their effect on triglyceride accumulation and ROS production, identifying the differential expression of genes involved in fatty liver and oxidative stress development. In vitro steatosis was induced in HepG2 cells and the protective effect of curcumin, andrographolide, and their combination was observed evaluating cell viability, lipid and triglyceride content, ROS levels, and microarray differential gene expression. Curcumin, andrographolide, and their association were effective in reducing steatosis, triglyceride content, and ROS stress, downregulating the genes involved in lipid accumulation. Moreover, the treatments were able to protect the cytotoxic effect of steatosis, promoting the expression of survival and anti-inflammatory genes. The present study showed that the association of curcumin and andrographolide could be used as a therapeutic approach to counter high lipid content and ROS levels in steatosis liver, avoiding the possible hepatotoxic effect of curcumin. Furthermore, this study improved our understanding of the antisteatosis and hepatoprotective properties of a curcumin and andrographolide combination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
- Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy.
- Department of Agricultural, Food and Forest Sciences, University of Palermo, 90128 Palermo, Italy.
ORCID-Profile: Rosaria Maria Pipitone, Rossella Zito, Giulia Lupo, Gabriele Di Maria, Francesca Di Salvo, Simona Fontana, Daniela Carlisi, Stefania Grimaudo
Förderung
- Regione Siciliana
- university of palermo
- PO FESR Sicilia 2014/2020
Zitieren
APA
Pipitone, R. M., Zito, R., Lupo, G., Javed, A., La Mantia, C., Di Maria, G., Pratelli, G., Di Salvo, F., Fontana, S., Pucci, M., Carlisi, D., & Grimaudo, S. (2023). Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line. Molecules, 28(3), 1261. https://doi.org/10.3390/molecules28031261
Vancouver
Pipitone RM, Zito R, Lupo G, Javed A, La Mantia C, Di Maria G, et al. Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line. Molecules. 2023;28(3):1261. doi:10.3390/molecules28031261
BibTeX
@article{Pipitone2023,
author = {Pipitone, Rosaria Maria and Zito, Rossella and Lupo, Giulia and Javed, Ayesha and La Mantia, Claudia and Di Maria, Gabriele and Pratelli, Giovanni and Di Salvo, Francesca and Fontana, Simona and Pucci, Marzia and Carlisi, Daniela and Grimaudo, Stefania},
title = {Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line},
journal = {Molecules},
year = {2023},
volume = {28},
number = {3},
pages = {1261},
doi = {10.3390/molecules28031261}
}
EUVIMED